This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MLND

Millendo Therapeutics (MLND) Stock Price, News & Analysis

Millendo Therapeutics logo

About Millendo Therapeutics Stock (NASDAQ:MLND)

Key Stats

Today's Range
$1.54
▼
$1.61
50-Day Range
$3.06
▼
$5.84
52-Week Range
$0.92
▼
$16.95
Volume
152,321 shs
Average Volume
1.52 million shs
Market Capitalization
$29.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

As of June 25, 2021, Millendo Therapeutics, Inc. was acquired by Tempest Therapeutics Inc., in a reverse merger transaction. Millendo Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Ann Arbor, Michigan.

Receive MLND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Millendo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MLND Stock News Headlines

Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
Maxim Group Maintains Their Buy Rating on Mind Medicine (MMED)
Expert Ratings for Decibel Therapeutics
See More Headlines

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:MLND
CIK
N/A
Fax
N/A
Employees
12
Year Founded
2012

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$36.41 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-91.03%
Return on Assets
-72.44%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.39
Quick Ratio
6.39

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.78 per share
Price / Book
0.88

Miscellaneous

Outstanding Shares
19,043,000
Free Float
N/A
Market Cap
$29.71 million
Optionable
Not Optionable
Beta
0.48

Social Links

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (NASDAQ:MLND) was last updated on 4/8/2026 by MarketBeat.com Staff.
From Our Partners